Player FM 앱으로 오프라인으로 전환하세요!
EP442: A Short Rumination on Saving Money, Except Not Saving Money. Oncology Side Effect Management as a Case Study, With Andreas Mang
Manage episode 425889353 series 2701020
In Episode 442 of 'Relentless Health Value,' host Stacey Richter shares an intriguing outtake from a previous episode featuring Andreas Mang, senior managing director at Blackstone, discussing the critical issue of cost management in oncology side effect treatment.
The conversation delves into the inefficiencies and patient harms caused by inadequate side effect management, particularly dehydration due to chemotherapy, and the resulting financial burdens on employers, taxpayers, and patients.
Stacey explores the importance of a value-based mindset in drug purchasing, integrating oncology care, and the potential financial and health benefits of better side effect management. She highlights various expert opinions and studies supporting these points, encouraging listeners to reconsider their approach to healthcare cost structures and patient care protocols.
If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe.
01:12 Andreas Mang on oncology medication side effect management.
03:12 Mark Lewis, MD’s Tweet.
03:39 Celena Latham’s response.
04:22 How integrative oncology can save money and what it looks like.
04:47 EP157 with Ethan Basch, MD.
06:20 Why PBMs saving money doesn’t necessarily mean savings for employers and payers.
07:36 EP435 with Dan Mendelson.
08:20 EP372 with Cora Opsahl.
08:40 EP331 with Al Lewis.
09:50 Stacey’s second rumination.
10:19 Why having a value mindset when purchasing is a thing.
10:42 Stacey’s third rumination.
12:03 EP370 with Erik Davis and Autumn Yongchu.
13:07 Why FFS does not pay or pay adequately for side effect management.
14:31 Stacey’s final rumination.
17:08 Summarizing Stacey’s four ruminations on this topic.
546 에피소드
Manage episode 425889353 series 2701020
In Episode 442 of 'Relentless Health Value,' host Stacey Richter shares an intriguing outtake from a previous episode featuring Andreas Mang, senior managing director at Blackstone, discussing the critical issue of cost management in oncology side effect treatment.
The conversation delves into the inefficiencies and patient harms caused by inadequate side effect management, particularly dehydration due to chemotherapy, and the resulting financial burdens on employers, taxpayers, and patients.
Stacey explores the importance of a value-based mindset in drug purchasing, integrating oncology care, and the potential financial and health benefits of better side effect management. She highlights various expert opinions and studies supporting these points, encouraging listeners to reconsider their approach to healthcare cost structures and patient care protocols.
If you enjoy this podcast, be sure to subscribe to the free weekly newsletter to be a member of the Relentless Tribe.
01:12 Andreas Mang on oncology medication side effect management.
03:12 Mark Lewis, MD’s Tweet.
03:39 Celena Latham’s response.
04:22 How integrative oncology can save money and what it looks like.
04:47 EP157 with Ethan Basch, MD.
06:20 Why PBMs saving money doesn’t necessarily mean savings for employers and payers.
07:36 EP435 with Dan Mendelson.
08:20 EP372 with Cora Opsahl.
08:40 EP331 with Al Lewis.
09:50 Stacey’s second rumination.
10:19 Why having a value mindset when purchasing is a thing.
10:42 Stacey’s third rumination.
12:03 EP370 with Erik Davis and Autumn Yongchu.
13:07 Why FFS does not pay or pay adequately for side effect management.
14:31 Stacey’s final rumination.
17:08 Summarizing Stacey’s four ruminations on this topic.
546 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.